iRadimed
IRMD
74 hedge funds and large institutions have $159M invested in iRadimed in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 4 closing their positions.
300% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 4
19% more funds holding
Funds holding: 62 → 74 (+12)
18% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 22
13% more capital invested
Capital invested by funds: $141M → $159M (+$18.3M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.42% less ownership
Funds ownership: 38.78% → 38.36% (-0.42%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$2.19M |
| 2 |
BCM
Bares Capital Management
Austin,
Texas
|
+$2.1M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$1.62M |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
+$879K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$755K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$3.13M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.87M |
| 3 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$2.15M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.58M |
| 5 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
-$1.41M |
IRMD Hedge Fund Activity: Q3 2021 in Review
74 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2021, worth a combined $159M — up 13% from $141M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new IRMD positions and 4 closed out — a net gain of 12 holders — while 26 added to existing stakes and 22 trimmed.
The largest buyer was Hillsdale Investment Management, opening a new position worth an estimated $2.19M. The largest seller was Rice Hall James & Associates, cutting an estimated $3.13M.
- 74 institutional investors held iRadimed (IRMD) as of Q3 2021, up from 62 in Q2 2021.
- Funds reported $159M of iRadimed stock for Q3 2021, up 13% quarter-over-quarter.
- 16 funds opened new iRadimed positions in Q3 2021 and 4 closed out, a net change of +12 holders.
- The largest iRadimed buyer in Q3 2021 was Hillsdale Investment Management, an estimated $2.19M added.
- The largest iRadimed seller in Q3 2021 was Rice Hall James & Associates, an estimated $3.13M sold.
Based on aggregated 13F filings for Q3 2021.